Learn More
Medchemexpress LLC PKSI-527 | 128837-71-8 | MFCD01745772 | 98.1% | 473.99 g/mol | C25H32ClN3O4 | 5MG

Supplier: Medchemexpress LLC HY1231335MG
PKSI-527 is a small-molecule, highly selective plasma kallikrein inhibitor used in preclinical research. It has been shown to suppress collagen-induced arthritis by modulating the kallikrein-kinin system. The compound is supplied as a powder and is also available as a 10 mM solution in DMSO to support various in vitro and in vivo study formats.
- Highly selective plasma kallikrein inhibition for target validation and mechanistic studies.
- Demonstrated activity in collagen-induced arthritis models.
- Available as a powder and as a 10 mM solution in DMSO for experimental flexibility.
- Multiple package sizes support small-scale screening and larger preclinical studies.
- Characterized by molecular formula C25H32ClN3O4 and molecular weight 473.99 g/mol.
- Typical assay purity reported around 98% by HPLC; certificate of analysis available per batch.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.